File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Well-differentiated epithelial thyroid cancer management in the Asia Pacific region: A report and clinical practice guideline

TitleWell-differentiated epithelial thyroid cancer management in the Asia Pacific region: A report and clinical practice guideline
Authors
Issue Date2006
PublisherMary Ann Liebert, Inc Publishers. The Journal's web site is located at http://www.liebertpub.com/thy
Citation
Thyroid, 2006, v. 16 n. 5, p. 461-469 How to Cite?
AbstractContext: Thyroid cancer is among the 10 most common malignancies in populations in the Asia Pacific region, where access to various relevant health care resources varies widely. Objective: An expert consensus conference was held to define regional patterns of practice and guidelines for optimal management of well-differentiated epithelial thyroid carcinomas. Results: Practice patterns vary from country to country, as would be anticipated form their variety of ethnic and racial populations, health care systems, economies, and cultures. Thyroid cancer care is provided by a number of medical and surgical specialists, usually including endocrinologists. The thyroid surgical skills, experience, and outcomes vary widely in the region. Radioiodine is available, to a greater or lesser extent, is almost all countries. Laboratory services for thyroid function monitoring are universally accessible; thyroglobulin assays are available in most countries. Recombinant thyrotropin is approved for use in only two countries, but can be accessed in some others on a "named patient" compassionate need basis. Access to advanced imaging, for example, positron emission tomography (PET) scanning, is limited to a few countries. Conclusions: In light of these realities, appropriate strategies for initial treatment and postoperative monitoring of patients with thyroid cancer have been defined, and these are presented and discussed. © Mary Ann Liebert, Inc.
Persistent Identifierhttp://hdl.handle.net/10722/77261
ISSN
2023 Impact Factor: 5.8
2023 SCImago Journal Rankings: 1.889
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorSundram, Fen_HK
dc.contributor.authorRobinson, BGen_HK
dc.contributor.authorKung, Aen_HK
dc.contributor.authorLimAbrahan, MAen_HK
dc.contributor.authorBay, NQen_HK
dc.contributor.authorChuan, LKen_HK
dc.contributor.authorChung, JHen_HK
dc.contributor.authorHuang, SMen_HK
dc.contributor.authorHsu, LCen_HK
dc.contributor.authorKamaruddin, Nen_HK
dc.contributor.authorCheah, WKen_HK
dc.contributor.authorKim, WBen_HK
dc.contributor.authorKoong, SSen_HK
dc.contributor.authorLin, HDen_HK
dc.contributor.authorMangklabruks, Aen_HK
dc.contributor.authorPazPacheco, Een_HK
dc.contributor.authorRauff, Aen_HK
dc.contributor.authorLadenson, PWen_HK
dc.date.accessioned2010-09-06T07:30:00Z-
dc.date.available2010-09-06T07:30:00Z-
dc.date.issued2006en_HK
dc.identifier.citationThyroid, 2006, v. 16 n. 5, p. 461-469en_HK
dc.identifier.issn1050-7256en_HK
dc.identifier.urihttp://hdl.handle.net/10722/77261-
dc.description.abstractContext: Thyroid cancer is among the 10 most common malignancies in populations in the Asia Pacific region, where access to various relevant health care resources varies widely. Objective: An expert consensus conference was held to define regional patterns of practice and guidelines for optimal management of well-differentiated epithelial thyroid carcinomas. Results: Practice patterns vary from country to country, as would be anticipated form their variety of ethnic and racial populations, health care systems, economies, and cultures. Thyroid cancer care is provided by a number of medical and surgical specialists, usually including endocrinologists. The thyroid surgical skills, experience, and outcomes vary widely in the region. Radioiodine is available, to a greater or lesser extent, is almost all countries. Laboratory services for thyroid function monitoring are universally accessible; thyroglobulin assays are available in most countries. Recombinant thyrotropin is approved for use in only two countries, but can be accessed in some others on a "named patient" compassionate need basis. Access to advanced imaging, for example, positron emission tomography (PET) scanning, is limited to a few countries. Conclusions: In light of these realities, appropriate strategies for initial treatment and postoperative monitoring of patients with thyroid cancer have been defined, and these are presented and discussed. © Mary Ann Liebert, Inc.en_HK
dc.languageengen_HK
dc.publisherMary Ann Liebert, Inc Publishers. The Journal's web site is located at http://www.liebertpub.com/thyen_HK
dc.relation.ispartofThyroiden_HK
dc.subject.meshAntineoplastic Agents - therapeutic useen_HK
dc.subject.meshAsiaen_HK
dc.subject.meshCell Differentiationen_HK
dc.subject.meshEndocrinology - methodsen_HK
dc.subject.meshFemaleen_HK
dc.subject.meshHumansen_HK
dc.subject.meshMaleen_HK
dc.subject.meshNeoplasms, Glandular and Epithelial - epidemiology - pathology - therapyen_HK
dc.subject.meshThyroid Neoplasms - epidemiology - pathology - therapyen_HK
dc.titleWell-differentiated epithelial thyroid cancer management in the Asia Pacific region: A report and clinical practice guidelineen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1050-7256&volume=16&spage=461&epage=9&date=2006&atitle=Well-differentiated+epithelial+thyroid+cancer+management+in+the+Asia+Pacific+Region:+A+report+and+clinical+practice+guidelineen_HK
dc.identifier.emailKung, A:awckung@hku.hken_HK
dc.identifier.authorityKung, A=rp00368en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1089/thy.2006.16.461en_HK
dc.identifier.pmid16756468-
dc.identifier.scopuseid_2-s2.0-33745190962en_HK
dc.identifier.hkuros131138en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-33745190962&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume16en_HK
dc.identifier.issue5en_HK
dc.identifier.spage461en_HK
dc.identifier.epage469en_HK
dc.identifier.isiWOS:000238443500007-
dc.publisher.placeUnited Statesen_HK
dc.identifier.scopusauthoridSundram, F=7003854039en_HK
dc.identifier.scopusauthoridRobinson, BG=7402517854en_HK
dc.identifier.scopusauthoridKung, A=7102322339en_HK
dc.identifier.scopusauthoridLimAbrahan, MA=6506231262en_HK
dc.identifier.scopusauthoridBay, NQ=14017838400en_HK
dc.identifier.scopusauthoridChuan, LK=36741507900en_HK
dc.identifier.scopusauthoridChung, JH=7409850994en_HK
dc.identifier.scopusauthoridHuang, SM=7405421403en_HK
dc.identifier.scopusauthoridHsu, LC=36725793500en_HK
dc.identifier.scopusauthoridKamaruddin, N=55213200700en_HK
dc.identifier.scopusauthoridCheah, WK=7003742214en_HK
dc.identifier.scopusauthoridKim, WB=34769825200en_HK
dc.identifier.scopusauthoridKoong, SS=6602356082en_HK
dc.identifier.scopusauthoridLin, HD=36048518700en_HK
dc.identifier.scopusauthoridMangklabruks, A=6602250982en_HK
dc.identifier.scopusauthoridPazPacheco, E=24067446000en_HK
dc.identifier.scopusauthoridRauff, A=7003855123en_HK
dc.identifier.scopusauthoridLadenson, PW=14621482200en_HK
dc.identifier.issnl1050-7256-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats